The invention provides biologically active erythropoietin (EPO) conjugate compositions
wherein a transglutaminase reaction is employed to covalently and site specifically
conjugate the EPO molecule to a non-antigenic hydrophilic polymer that can also
be covalently linked to an organic molecule either of which modification increases
the circulating serum half-life of the composition.